Trial Profile
Study investigating clinical effect and safety of tafluprost with reduced benzalkonium chloride content in glaucoma patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Tafluprost (Primary)
- Indications Glaucoma
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2015 New trial record